Disturbances of novel object exploration and recognition in a chronic ketamine mouse model of schizophrenia.

Abstract excerpt

Schizophrenia is a chronic and devastating disease with an overall lifetime risk of 1%. While positive symptoms of schizophrenia such as hallucinations and delusions are reduced by antipsychotic medication based on the inhibition of type 2 dopaminergic receptors (D2R), negative symptoms (e.g. reduced motivation) and cognitive symptoms (e.g. impaired working memory) of schizophrenia are not effectively treated by...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chronic Disease
• Share to Exploratory Behavior
• Share to Memory, Episodic